10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001683168-21-003464`
Period End Date	20210630
Filing Date	20210812
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	xenetic_i10q-063021_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 44 Cash Flow Statement 30 Stockholders Equity 25

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$11.53M	USD	Point-in-time
Cash	`Cash`	$9.28M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$917.83K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$841.96K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.37M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.20M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$809.99K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$715.90K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Total assets	`Assets`	$13.18M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.77M	shares	Point-in-time
Total assets	`Assets`	$10.92M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.75M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$305.09K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$327.40K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$609.53K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$653.13K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$958.21K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$936.93K	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$27.04K	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$7.96K	USD	Point-in-time
Total liabilities	`Liabilities`	$963.97K	USD	Point-in-time
Total liabilities	`Liabilities`	$966.17K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 8,773,683 and 8,772,198 shares issued as of June 30, 2021 and December 31, 2020, respectively; 8,746,692 and 8,745,207 shares outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$8.77K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 8,773,683 and 8,772,198 shares issued as of June 30, 2021 and December 31, 2020, respectively; 8,746,692 and 8,745,207 shares outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$8.77K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$194.32M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$194.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-179.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-176.90M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.95M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.18M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$112.93K	USD	1 Quarter
Total revenue	`Revenues`	$287.60K	USD	1 Quarter
Total revenue	`Revenues`	$169.68K	USD	2 Qtrs
Total revenue	`Revenues`	$478.82K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$307.90K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$667.55K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$524.55K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.82M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$787.49K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$890.70K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.72M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$2.98M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$2.38M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$1.42M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.10M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.50M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.21M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-982.46K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Other income	`OtherIncome`	$238.00	USD	1 Quarter
Other income	`OtherIncome`	$192.00	USD	1 Quarter
Other income	`OtherIncome`	$58.00	USD	2 Qtrs
Other income	`OtherIncome`	$1.12K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$28.62K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$20.73K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$80.11K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$43.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$20.97K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$44.12K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$28.82K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$80.17K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-953.64K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.26M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.75M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.75M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.29M	shares	1 Quarter

Cash Flow Statement 30 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.13M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-2.45M	USD	2 Qtrs
Depreciation	`Depreciation`	$757.00	USD	2 Qtrs
Depreciation	`Depreciation`	-	USD	2 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$17.16K	USD	2 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$13.77K	USD	2 Qtrs
Gain on settlement with vendor	`GainOnSettlementWithVendor`	-	USD	2 Qtrs
Gain on settlement with vendor	`GainOnSettlementWithVendor`	$-143.64K	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$277.33K	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$186.21K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.06K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-167.59K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.20K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-484.19K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.25M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.30M	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.25M	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.30M	USD	2 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.07M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.28M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.07M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.28M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.00	USD	2 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$229.00	USD	2 Qtrs

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.95M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time
Issuance of common stock to vendor	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	2 Qtrs
Issuance of common stock to vendor	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.73K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$277.33K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$186.21K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$109.92K	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	2 Qtrs
Exercise of purchase warrants	`ExerciseOfPurchaseWarrantsValue`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-953.64K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.95M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.